Circular RNA CircRNA-0039459 Promotes the Migration, Invasion, and Proliferation of Liver Cancer Cells Through the Adsorption of MiR-432
Overview
Authors
Affiliations
This study aimed to investigate the molecular mechanism of circular RNA circ-0039459 and its effects on the apoptosis, proliferation, invasion, and migration of hepatocellular carcinoma cells. The expression of circ-0039459, miR-432, and synoviolin 1 (SYVN1) mRNA was determined using real-time quantitative reverse transcription PCR. Cell proliferation was detected by cell counting kit-8 assay, and the apoptosis rate was detected using flow cytometry. Cell migration and invasion were detected using Transwell assay. The expression of E-cadherin, N-cadherin, and vimentin was detected using western blot. The targeting relationship between circ-0039459 and miR-432 as well as that between miR-432 and SYVN1 were detected using the dual-luciferase reporter and RNA pull-down assays. We found that circ-0039459 and SYVN1 mRNA were highly expressed, whereas miR-432 was lowly expressed in hepatocellular carcinoma cells and tissues. After treatment with ribonuclease R or actinomycin D, the expression of linear RNA was reduced, whereas that of circular RNA was not significantly changed. circ-0039459 knockdown or miR-432 overexpression can inhibit cell proliferation, invasion, and migration and the expression of N-cadherin and vimentin proteins in carcinoma cells as well as promote apoptosis and increase the E-cadherin level. circ-0039459 targeted and regulated miR-432, which targeted and regulated SYVN1. The decreased miR-432 expression reversed the effects of circ-0039459 knockout in cancer cells. Furthermore, SYVN1 overexpression reversed the effect of miR-432 overexpression in hepatoma cells. Hence, circ-0039459 can affect the proliferation, apoptosis, migration, and invasion of hepatocellular carcinoma cells through the adsorption of miR-432, thereby regulating the expression of SYVN1.
CircUSP10 promotes liver cancer progression by regulating miR-211-5p/TCF12/EMT signaling pathway.
Chen X, Xu Y, Zhou Z, Zhao P, Zhou Z, Wang F Heliyon. 2023; 9(10):e20649.
PMID: 37829805 PMC: 10565698. DOI: 10.1016/j.heliyon.2023.e20649.
Xu J, Zuo J, Han C, Li T, Jin D, Zhao F Naunyn Schmiedebergs Arch Pharmacol. 2023; 397(3):1727-1736.
PMID: 37721554 DOI: 10.1007/s00210-023-02708-x.
Sun Z, Liu Y, He X, Di R, Wang X, Ren C Int J Mol Sci. 2022; 23(23).
PMID: 36499219 PMC: 9737051. DOI: 10.3390/ijms232314888.